ResearcherKing's College LondonActive in the last 2 years
Nikolaos Ioannou
Matched on ORCID iD 0000-0002-7956-5543; OpenAlex author ID A5048332192. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- [Corrigendum] Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER‑inhibitors is accompanied by increased sensitivity to STAT3 … Co-author DOI 10.3892/ijo.2026.5948↗
- Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the id… Co-author DOI 10.3892/or.2020.7822↗
- Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition. Co-author DOI 10.3892/ijo.2016.3320↗
- Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human panc… Co-author DOI 10.1186/1471-2407-13-41↗
- Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancer. Co-author DOI 10.2741/4081↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Angus George Dalgleish · 4 shared papers, 2013–2026 · strength 0.60
- Paper [Corrigendum] Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER‑inhibitors is accomp… DOI 10.3892/ijo.2026.5948↗
- Paper Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of… DOI 10.3892/or.2020.7822↗
- Paper Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by incre… DOI 10.3892/ijo.2016.3320↗
- Helmout Modjtahedi · 4 shared papers, 2013–2026 · strength 0.60
- Paper [Corrigendum] Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER‑inhibitors is accomp… DOI 10.3892/ijo.2026.5948↗
- Paper Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of… DOI 10.3892/or.2020.7822↗
- Paper Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by incre… DOI 10.3892/ijo.2016.3320↗
- Tanzeel Khan · 1 shared paper, 2020 · strength 0.13
- Satvinder Mudan · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.